STAP1
Signal-transducing adaptor protein 1
Also known as: BRDG1, STAP-1, STAP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULZ2
- Gene
- STAP1
- Ensembl
- ENSG00000035720
- Chromosome
- 4
- Canonical length
- 295 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Cytosol
OverviewNCBI Gene
The protein encoded by this gene contains a proline-rich region, a pleckstrin homology (PH) domain, and a region in the carboxy terminal half with similarity to the Src Homology 2 (SH2) domain. This protein is a substrate of tyrosine-protein kinase Tec, and its interaction with tyrosine-protein kinase Tec is phosphorylation-dependent. This protein is thought to participate in a positive feedback loop by upregulating the activity of tyrosine-protein kinase Tec. Variants of this gene have been associated with autosomal-dominant hypercholesterolemia (ADH), which is characterized by elevated low-density lipoprotein cholesterol levels and in increased risk of coronary vascular disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
295 residues, UniProt reviewed canonical sequence.
>Q9ULZ2|STAP1
1 MMAKKPPKPA PRRIFQERLK ITALPLYFEG FLLIKRSGYR EYEHYWTELR GTTLFFYTDK
61 KSIIYVDKLD IVDLTCLTEQ NSTEKNCAKF TLVLPKEEVQ LKTENTESGE EWRGFILTVT
121 ELSVPQNVSL LPGQVIKLHE VLEREKKRRI ETEQSTSVEK EKEPTEDYVD VLNPMPACFY
181 TVSRKEATEM LQKNPSLGNM ILRPGSDSRN YSITIRQEID IPRIKHYKVM SVGQNYTIEL
241 EKPVTLPNLF SVIDYFVKET RGNLRPFICS TDENTGQEPS MEGRSEKLKK NPHIALocalizationUniProt · AlphaFold · HPA
Whether an antibody against STAP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 48 nTPM
- lymph node: 38 nTPM
- spleen: 15 nTPM
- appendix: 15 nTPM
- kidney: 8.6 nTPM
- small intestine: 7.2 nTPM
Single-cell type
- respiratory ionocytes: 1,207 nCPM
- epididymal clear cells: 617 nCPM
- renal collecting duct intercalated cells: 265 nCPM
- b-cells: 193 nCPM
- plasma cells: 186 nCPM
- mast cells: 118 nCPM
Immune cell
- naive B-cell: 108 nTPM
- memory B-cell: 89 nTPM
- NK-cell: 39 nTPM
- eosinophil: 24 nTPM
- naive CD4 T-cell: 7.9 nTPM
- basophil: 5.4 nTPM
Brain region
- hippocampal formation: 1.2 nTPM
- pons: 0.4 nTPM
- medulla oblongata: 0.3 nTPM
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- spinal cord: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STAP1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 183 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor protein tyrosine kinase signaling pathway
- cellular response to lipopolysaccharide
- negative regulation of macrophage chemotaxis
- negative regulation of macrophage colony-stimulating factor signaling pathway
- negative regulation of ruffle assembly
- positive regulation of B cell receptor signaling pathway
- positive regulation of gene expression
- positive regulation of microglial cell activation
- positive regulation of microglial cell mediated cytotoxicity
- positive regulation of phagocytosis, engulfment
- negative regulation of microglial cell migration
Molecular functions
- macrophage colony-stimulating factor receptor binding
- phospholipid binding
- phosphotyrosine residue binding
- protein kinase binding
- protein tyrosine kinase activator activity
- signaling adaptor activity
- transmembrane receptor protein tyrosine kinase adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STAP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STAP1 as an antibody target. Whether an autoantibody or antibody against STAP1 could matter depends on whether native STAP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STAP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STAP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...